Welcome to our dedicated page for Cross Ctry Healthcare SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cross Country Healthcare, Inc. (CCRN) SEC filings page on Stock Titan provides centralized access to the company’s public filings with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, Cross Country Healthcare submits a range of documents that detail its financial condition, governance, and material corporate events.
Investors can use this page to locate current and historical reports such as annual reports on Form 10‑K and quarterly updates on Form 10‑Q, which the company references in its proxy materials and earnings communications. These reports typically include audited or reviewed financial statements, segment information for Nurse and Allied Staffing and Physician Staffing, discussions of Homecare and Education staffing activities, and management’s analysis of operational efficiency, technology investments, and market conditions.
The filings page also surfaces current reports on Form 8‑K, which Cross Country Healthcare uses to disclose significant events. Recent examples include 8‑Ks reporting quarterly financial results furnished under Item 2.02, updates on the Agreement and Plan of Merger with Aya Healthcare and its termination, the automatic extension of the merger agreement end date, the scheduling of the 2025 Annual Meeting of Stockholders, and the CEO transition in which co‑founder and Chairman Kevin C. Clark was appointed President and Chief Executive Officer.
In addition, users can review the company’s definitive proxy statements on Schedule 14A, which describe board composition, director qualifications, executive compensation, and key proposals submitted to stockholders. These documents also summarize strategic priorities such as strengthening the operational foundation, advancing technology capabilities, and addressing workforce needs across healthcare, homecare, and education markets.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, helping readers quickly understand the implications of new 10‑K, 10‑Q, 8‑K, and proxy filings. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures, make it easier to track Cross Country Healthcare’s regulatory reporting and governance developments, including items related to potential transactions, capital allocation, and leadership changes.
AllianceBernstein L.P. filed Amendment No. 2 to a Schedule 13G/A reporting its beneficial ownership of Cross Country Healthcare Inc. common stock. As of 12/31/2025, AllianceBernstein reported beneficial ownership of 31,215 shares, representing 0.1% of the outstanding common stock.
The shares are held solely for investment purposes in client discretionary investment advisory accounts, with AllianceBernstein having sole voting and dispositive power over these shares and no shared power. The filing states the holdings are in the ordinary course of business and not for changing or influencing control of Cross Country Healthcare.
Cross Country Healthcare, Inc. is informing investors about its upcoming fourth quarter and full year 2025 earnings conference call. The call will take place on Wednesday, March 4, 2026 at 5:00 p.m. Eastern Time, with an earnings press release expected after market close that day.
The call will be accessible via live webcast on the company’s investor relations website at ir.crosscountry.com and by phone using listed U.S. and international dial-in numbers with the passcode “Cross Country.” A replay will be available online and by telephone from March 4 through March 18.
The filing presents this information under a Regulation FD disclosure item and includes a furnished press release as an exhibit, outlining the call logistics and offering a brief description of Cross Country Healthcare’s technology-driven healthcare workforce solutions business.
Cross Country Healthcare, Inc. has set May 11, 2026 as the date for its virtual-only 2026 Annual Meeting of Stockholders. Details on the meeting time and website will appear in the proxy statement, which is expected to be made available on or about March 31, 2026.
Stockholder proposals for inclusion in the proxy statement under Rule 14a-8 must reach the company’s principal executive office by the close of business on March 11, 2026. Under the company’s bylaws, notices to propose other business or nominate directors must be delivered by February 10, 2026.
To use the universal proxy rules for director nominees other than the company’s, stockholders must provide the information required by Rule 14a-19 by March 12, 2026. All materials are to be sent to the Corporate Secretary at the Boca Raton, Florida headquarters.
Cross Country Healthcare’s General Counsel and Secretary, Susan E. Ball, reported an amended insider transaction reflecting tax withholding tied to restricted stock vesting. On March 31, 2025, multiple entries show shares of common stock withheld to cover tax obligations, including transactions of 1,740, 1,689, 2,015 and 3,942 shares at a price of $14.89 per share. These were coded as “F,” indicating shares withheld by the issuer rather than open-market sales. After these transactions, she directly beneficially owned 176,032 shares of Cross Country Healthcare common stock. The amendment corrects the transaction date originally reported as April 2, 2025, confirming that the activity occurred on March 31, 2025.
Cross Country Healthcare Inc. reported that its Chief Accounting Officer received a grant of 12,311 restricted shares of common stock on December 18, 2025. These shares were granted at a price of $0 and increase the officer’s directly owned common stock to 31,110 shares after the transaction.
The restricted stock award will vest in three substantially equal installments on December 18, 2026, March 31, 2027, and March 31, 2028. The Compensation Committee approved the number of restricted shares to be granted on December 18, 2025, following the termination of a Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the first vesting date 12 months from grant, the remaining installments will vest on March 31 of the next two years to align with prior awards.
Cross Country Healthcare, Inc. reported that director Kevin C. Clark received a grant of 162,672 restricted shares of common stock on December 18, 2025 at a price of $0. These restricted stock awards vest in three substantially equal installments on December 18, 2026, March 31, 2027, and March 31, 2028, with later vesting dates aligned to the company’s existing restricted stock schedule.
The grant amount was approved on December 18, 2025 following the termination of a Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After this award, Mr. Clark beneficially owns 809,170 shares directly and 3,961 shares indirectly through his spouse, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Cross Country Healthcare, Inc. reported that its General Counsel and Secretary, Susan E. Ball, received a grant of 35,804 restricted shares of common stock on December 18, 2025 at a stated price of $0. Following this grant, she beneficially owns 211,836 shares directly.
The restricted shares vest in three substantially equal installments on December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee approved the number of restricted shares to be granted on December 18, 2025 instead of March 31, 2025, after the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.
Cross Country Healthcare announced a major leadership change as President and Chief Executive Officer John A. Martins separated from the company effective December 14, 2025, and stepped down from the board, which was reduced from seven to six members. The board appointed current chairman, former CEO, and co‑founder Kevin C. Clark as President and CEO, effective the same date, and he will continue to serve as chairman.
Under his employment agreement, Martins will receive cash severance equal to two years of his base salary of $875,000 plus two times his average actual bonus over the prior three years, paid over 24 months, along with up to 24 months of continued benefits if elected. All of his unvested equity awards will fully vest, with outstanding performance share awards vesting at target. The company plans to finalize an employment agreement setting Clark’s compensation and intends to file an amendment when those terms are determined.
Cross Country Healthcare (CCRN) filed its Q3 2025 10‑Q, reporting revenue of $250,052 thousand and a net loss of $4,774 thousand, or $0.15 per diluted share. For the nine months, revenue was $817,532 thousand with a net loss of $11,923 thousand.
Results reflected softer volumes and several non-core charges. The quarter included $4,147 thousand of Aya Merger-related fees, $1,530 thousand of restructuring costs, and $1,102 thousand of legal and other losses. Operating loss was $5,973 thousand. Nurse and Allied Staffing generated $201,950 thousand of revenue; Physician Staffing contributed $48,102 thousand.
Liquidity remained solid: cash and cash equivalents were $99,132 thousand with no debt outstanding. The asset‑based revolver had $121.4 million of borrowing base availability, or $103.0 million net of $18.4 million in letters of credit. Operating cash flow was $30,012 thousand year‑to‑date. The pending Aya Merger remains subject to FTC review under the HSR Act; the HSR waiting period extends during the government shutdown, and the parties are discussing an end‑date extension.